{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:43:18Z","timestamp":1791088998526,"version":"4.1.0"},"reference-count":119,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.crohns.2009.11.005","type":"journal-article","created":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T14:48:44Z","timestamp":1259678924000},"page":"257-268","source":"Crossref","is-referenced-by-count":121,"title":["The joint\u2013gut axis in inflammatory bowel diseases"],"prefix":"10.1093","volume":"4","author":[{"given":"Lianne K.P.M.","family":"Brakenhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e M.","family":"van der Heijde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Hommes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W.J.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herma H.","family":"Fidder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.crohns.2009.11.005_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","article-title":"The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients","volume":"55","author":"Greenstein","year":"1976","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.crohns.2009.11.005_bib3","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","article-title":"Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study","volume":"9","author":"Lakatos","year":"2003","journal-title":"World J Gastroenterol"},{"issue":"4 Pt 2","key":"10.1016\/j.crohns.2009.11.005_bib4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0016-5085(79)90391-3","article-title":"National cooperative Crohn's disease study: extraintestinal manifestations and perianal complications","volume":"77","author":"Rankin","year":"1979","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","article-title":"Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients","volume":"23","author":"Veloso","year":"1996","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10067-007-0797-5","article-title":"A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations","volume":"27","author":"Lanna","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"4 Pt 2","key":"10.1016\/j.crohns.2009.11.005_bib7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0016-5085(79)90389-5","article-title":"Clinical features and natural history of Crohn's disease","volume":"77","author":"Mekhjian","year":"1979","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.crohns.2009.11.005_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.42.3.387","article-title":"Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history","volume":"42","author":"Orchard","year":"1998","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/003655201317097173","article-title":"Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients","volume":"36","author":"Salvarani","year":"2001","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"10.1016\/j.crohns.2009.11.005_bib10","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib11","first-page":"2860","article-title":"Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association","volume":"27","author":"de Vlam","year":"2000","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/ard.37.1.33","article-title":"Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease","volume":"37","author":"Dekker-Saeys","year":"1978","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.crohns.2009.11.005_bib13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/rheumatology\/40.11.1256","article-title":"The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study)","volume":"40","author":"Palm","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"4 Pt 1","key":"10.1016\/j.crohns.2009.11.005_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0016-5085(75)80270-8","article-title":"Clinical patterns in Crohn's disease: a statistical study of 615 cases","volume":"68","author":"Farmer","year":"1975","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.crohns.2009.11.005_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.CSMR.0000306082.20688.8e","article-title":"Inflammatory bowel disease arthropathy","volume":"4","author":"Moeller","year":"2005","journal-title":"Curr Sports Med Rep"},{"issue":"3","key":"10.1016\/j.crohns.2009.11.005_bib16","first-page":"511","article-title":"Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study)","volume":"29","author":"Palm","year":"2002","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.crohns.2009.11.005_bib17","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S1590-8658(08)60534-4","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"40","author":"Ardizzone","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"Suppl 1","key":"10.1016\/j.crohns.2009.11.005_bib18","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gut.2005.081950c","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: special situations","volume":"55","author":"Caprilli","year":"2006","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.crohns.2009.11.005_bib19","first-page":"1755","article-title":"Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life","volume":"32","author":"Palm","year":"2005","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/berh.2002.0249","article-title":"Ankylosing spondylitis and bowel disease","volume":"16","author":"Baeten","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1440-1746.2007.05108.x","article-title":"Clinical and genetic factors associated with sacroiliitis in Crohn's disease","volume":"23","author":"Peeters","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s100670070003","article-title":"Subclinical sacroiliitis in inflammatory bowel disease: a clinical and follow-up study","volume":"19","author":"Queiro","year":"2000","journal-title":"Clin Rheumatol"},{"issue":"24","key":"10.1016\/j.crohns.2009.11.005_bib23","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.1977.03270510035017","article-title":"Clinical history as a screening test for ankylosing spondylitis","volume":"237","author":"Calin","year":"1977","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.crohns.2009.11.005_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.21619","article-title":"Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria","volume":"54","author":"Rudwaleit","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib26","first-page":"2853","article-title":"Spondyloarthropathies","volume":"69","author":"Kataria","year":"2004","journal-title":"Am Fam Physician"},{"issue":"9","key":"10.1016\/j.crohns.2009.11.005_bib27","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/ard.2003.019968","article-title":"Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional X-rays with magnetic resonance imaging using established and new scoring systems","volume":"63","author":"Braun","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/ard.2008.101501","article-title":"New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 4","key":"10.1016\/j.crohns.2009.11.005_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2036.2004.02044.x","article-title":"Review article: joint involvement in inflammatory bowel disease","volume":"20","author":"de Vos","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.crohns.2009.11.005_bib32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0889-857X(03)00043-7","article-title":"Enteropathic arthritis","volume":"29","author":"Holden","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.crohns.2009.11.005_bib33","first-page":"518","article-title":"Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease","volume":"30","author":"Steer","year":"2003","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib34","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ibd.20038","article-title":"Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestations","volume":"13","author":"Koutroubakis","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib35","first-page":"23","article-title":"Destructive lesions of small joints in seronegative spondylarthropathies: relation to gut inflammation","volume":"8","author":"Mielants","year":"1990","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib36","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/ibd.20942","article-title":"Musculoskeletal manifestations of inflammatory bowel disease","volume":"15","author":"Bourikas","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.crohns.2009.11.005_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/rheumatology\/ken032","article-title":"What is the primary lesion in SpA dactylitis?","volume":"47","author":"Olivieri","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib38","first-page":"51","article-title":"Imaging of sacroiliitis","volume":"19","author":"Braun","year":"2000","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib39","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.20990","article-title":"The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?","volume":"52","author":"Rudwaleit","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.crohns.2009.11.005_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","article-title":"Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis","volume":"23","author":"Feldtkeller","year":"2003","journal-title":"Rheumatol Int"},{"issue":"11","key":"10.1016\/j.crohns.2009.11.005_bib41","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/ard.2007.083089","article-title":"The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research","volume":"67","author":"Song","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s002560050388","article-title":"Comparison of radiography, computed tomography and magnetic resonance imaging in the detection of sacroiliitis accompanying ankylosing spondylitis","volume":"27","author":"Yu","year":"1998","journal-title":"Skeletal Radiol"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib43","first-page":"2107","article-title":"Magnetic resonance imaging (MRI) for detection of active sacroiliitis\u2014a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI","volume":"23","author":"Blum","year":"1996","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.crohns.2009.11.005_bib44","first-page":"1953","article-title":"Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study","volume":"26","author":"Oostveen","year":"1999","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.crohns.2009.11.005_bib45","first-page":"393","article-title":"Magnetic resonance imaging in the detection of sacroiliitis","volume":"19","author":"Docherty","year":"1992","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.crohns.2009.11.005_bib46","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00296-004-0490-9","article-title":"The investigation of sacroiliitis with different imaging techniques in spondyloarthropathies","volume":"25","author":"Inanc","year":"2005","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.crohns.2009.11.005_bib47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/03009740410005881","article-title":"MRI abnormalities of sacroiliac joints in early spondylarthropathy: a 1-year follow-up study","volume":"33","author":"Puhakka","year":"2004","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1148\/radiology.180.1.2052702","article-title":"Sacroiliitis: MR imaging findings","volume":"180","author":"Murphey","year":"1991","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.crohns.2009.11.005_bib49","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/ard.2009.110767","article-title":"Defining active sacroiliitis on Magnetic Resonance Imaging (MRI) for classification of axial spondyloarthritis \u2014 a consensual approach by the ASAS\/ OMERACT MRI Group","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib50","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1521-6942(02)90250-0","article-title":"Imaging and scoring in ankylosing spondylitis","volume":"16","author":"Braun","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"30","key":"10.1016\/j.crohns.2009.11.005_bib51","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","article-title":"Extraintestinal manifestations and complications in inflammatory bowel diseases","volume":"12","author":"Rothfuss","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib52","first-page":"2273","article-title":"The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib53","first-page":"2279","article-title":"The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib54","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1053\/gast.1996.v110.pm8964393","article-title":"Long-term evolution of gut inflammation in patients with spondyloarthropathy","volume":"110","author":"de Vos","year":"1996","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib55","first-page":"2266","article-title":"The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.crohns.2009.11.005_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00054725-199805000-00026","article-title":"Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD","volume":"4","author":"Salmi","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2009.11.005_bib57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.0105-2896.2005.00285.x","article-title":"Lymphocyte homing to the gut: attraction, adhesion, and commitment","volume":"206","author":"Salmi","year":"2005","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib58","first-page":"125","article-title":"The sequence of changes in blood flow and lymphocyte influx to stimulated rat lymph nodes","volume":"44","author":"Drayson","year":"1981","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib59","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.136.4.697","article-title":"Blood microcirculation in the lymph node during the primary immune response","volume":"136","author":"Herman","year":"1972","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib60","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1084\/jem.143.4.870","article-title":"The effects of antigen on the migration of recirculating lymphocytes through single lymph nodes","volume":"143","author":"Cahill","year":"1976","journal-title":"J Exp Med"},{"issue":"6917","key":"10.1016\/j.crohns.2009.11.005_bib61","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.181.1.137","article-title":"Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms","volume":"181","author":"Salmi","year":"1995","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib63","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1053\/gast.2000.20173","article-title":"Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy","volume":"119","author":"May","year":"2000","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.crohns.2009.11.005_bib64","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1172\/JCI119389","article-title":"Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion","volume":"99","author":"Salmi","year":"1997","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.crohns.2009.11.005_bib65","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.166.7.4650","article-title":"Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules","volume":"166","author":"Salmi","year":"2001","journal-title":"J Immunol"},{"issue":"6837","key":"10.1016\/j.crohns.2009.11.005_bib66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.crohns.2009.11.005_bib67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1132","article-title":"The immunological and genetic basis of inflammatory bowel disease","volume":"3","author":"Bouma","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"6837","key":"10.1016\/j.crohns.2009.11.005_bib68","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"issue":"9272","key":"10.1016\/j.crohns.2009.11.005_bib69","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(00)05063-7","article-title":"Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations","volume":"357","author":"Hampe","year":"2001","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.crohns.2009.11.005_bib70","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/07853890701576172","article-title":"Nod-like receptors in innate immunity and inflammatory diseases","volume":"39","author":"Carneiro","year":"2007","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib71","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2003.50019","article-title":"Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan","volume":"124","author":"Bonen","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.crohns.2009.11.005_bib72","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.micinf.2007.01.016","article-title":"How NOD2 mutations predispose to Crohn's disease?","volume":"9","author":"Vignal","year":"2007","journal-title":"Microbes Infect"},{"issue":"9","key":"10.1016\/j.crohns.2009.11.005_bib73","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.2004.021774","article-title":"Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease","volume":"63","author":"Peeters","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.crohns.2009.11.005_bib74","first-page":"1959","article-title":"Analysis of CARD15 polymorphisms in Korean patients with ankylosing spondylitis reveals absence of common variants seen in western populations","volume":"31","author":"Kim","year":"2004","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.gene.6363914","article-title":"CARD15 gene mutations are not associated with ankylosing spondylitis","volume":"4","author":"van der Paardt","year":"2003","journal-title":"Genes Immun"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib76","first-page":"102","article-title":"Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease","volume":"30","author":"Ferreiros-Vidal","year":"2003","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.crohns.2009.11.005_bib77","first-page":"2470","article-title":"The Crohn's associated NOD2 3020InsC frameshift mutation does not confer susceptibility to ankylosing spondylitis","volume":"29","author":"D'Amato","year":"2002","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib78","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/art.10329","article-title":"Role of NOD2 variants in spondylarthritis","volume":"46","author":"Crane","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib79","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/ard.2004.028837","article-title":"CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease","volume":"64","author":"Laukens","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib80","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/1529-0131(200112)44:12<2728::AID-ART459>3.0.CO;2-8","article-title":"Inflammatory bowel disease and spondylarthropathy","volume":"44","author":"Smale","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib81","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/gut.28.4.394","article-title":"Histopathology of intestinal inflammation related to reactive arthritis","volume":"28","author":"Cuvelier","year":"1987","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.crohns.2009.11.005_bib82","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0092-8674(90)90512-D","article-title":"Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders","volume":"63","author":"Hammer","year":"1990","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib83","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","article-title":"The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats","volume":"180","author":"Taurog","year":"1994","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib84","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/ard.55.4.268","article-title":"HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom","volume":"55","author":"Brown","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib85","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00002281-200107000-00006","article-title":"Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset","volume":"13","author":"Olivieri","year":"2001","journal-title":"Curr Opin Rheumatol"},{"issue":"8872","key":"10.1016\/j.crohns.2009.11.005_bib86","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0140-6736(93)91760-J","article-title":"HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis","volume":"342","author":"Hermann","year":"1993","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.crohns.2009.11.005_bib87","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.berh.2006.03.004","article-title":"Major histocompatibility genes and ankylosing spondylitis","volume":"20","author":"Reveille","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.crohns.2009.11.005_bib88","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/path.1044","article-title":"Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy","volume":"196","author":"Baeten","year":"2002","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.crohns.2009.11.005_bib89","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/ard.2003.018382","article-title":"Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163","volume":"64","author":"Demetter","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.crohns.2009.11.005_bib90","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/ard.59.3.211","article-title":"Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin\/catenin complex","volume":"59","author":"Demetter","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3 Pt 1","key":"10.1016\/j.crohns.2009.11.005_bib91","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1097\/MCG.0b013e3181662455","article-title":"Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease","volume":"42","author":"Karimi","year":"2008","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.crohns.2009.11.005_bib92","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/00365529850171693","article-title":"Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis","volume":"33","author":"Elewaut","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.crohns.2009.11.005_bib93","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ajg.2009.15","article-title":"Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?","volume":"104","author":"Singh","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib94","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2007.12.001","article-title":"European evidence-based consensus on the management of ulcerative colitis: special situations","volume":"2","author":"Biancone","year":"2008","journal-title":"J Crohn\u2019s Colitis"},{"issue":"10","key":"10.1016\/j.crohns.2009.11.005_bib95","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00228-009-0719-3","article-title":"Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?","volume":"65","author":"Kefalakes","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.crohns.2009.11.005_bib96","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","article-title":"Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study","volume":"4","author":"Sandborn","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.crohns.2009.11.005_bib97","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1365-2036.2003.01596.x","article-title":"An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia","volume":"17","author":"Reinisch","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib98","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2002.05608.x","article-title":"Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease","volume":"97","author":"Mahadevan","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.crohns.2009.11.005_bib99","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1572-0241.2006.00384.x","article-title":"The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases","volume":"101","author":"El","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2005.041137","article-title":"ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"65","author":"Zochling","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib101","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","article-title":"Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab","volume":"43","author":"Brandt","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.crohns.2009.11.005_bib102","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/ard.61.3.207","article-title":"Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up","volume":"61","author":"Kruithof","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.crohns.2009.11.005_bib103","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/art.511","article-title":"Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy","volume":"46","author":"van den Bosch","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"24","key":"10.1016\/j.crohns.2009.11.005_bib104","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.2165\/00003495-200464240-00005","article-title":"Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis","volume":"64","author":"de Keyser","year":"2004","journal-title":"Drugs"},{"issue":"9313","key":"10.1016\/j.crohns.2009.11.005_bib105","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"issue":"9244","key":"10.1016\/j.crohns.2009.11.005_bib106","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(00)03239-6","article-title":"Crohn\u2019s disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms","volume":"356","author":"van den Bosch","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.crohns.2009.11.005_bib107","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00124743-200104000-00002","article-title":"Crohn\u2019s disease arthritis treated with infliximab: an open trial in four patients","volume":"7","author":"Ellman","year":"2001","journal-title":"J Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.crohns.2009.11.005_bib108","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/j.1572-0241.2002.06064.x","article-title":"Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn\u2019s disease","volume":"97","author":"Herfarth","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib109","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/ard.2003.012450","article-title":"Infliximab in spondyloarthropathy associated with Crohn\u2019s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations","volume":"63","author":"Generini","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00296-004-0467-8","article-title":"The effect of infliximab on extraintestinal manifestations of Crohn\u2019s disease","volume":"25","author":"Kaufman","year":"2005","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.crohns.2009.11.005_bib111","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/03009740510026698","article-title":"Infliximab in the treatment of extra-intestinal manifestations of Crohn\u2019s disease","volume":"34","author":"Rispo","year":"2005","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"10.1016\/j.crohns.2009.11.005_bib112","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1002\/art.21426","article-title":"Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies","volume":"52","author":"Kruithof","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.crohns.2009.11.005_bib113","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO;2-H","article-title":"Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study","volume":"44","author":"Marzo-Ortega","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.crohns.2009.11.005_bib114","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.crohns.2009.11.005_bib115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.62.1.74","article-title":"Efficacy of etanercept for treatment of Crohn\u2019s related spondyloarthritis but not colitis","volume":"62","author":"Marzo-Ortega","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.crohns.2009.11.005_bib116","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/art.22887","article-title":"Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study","volume":"57","author":"Davis","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.crohns.2009.11.005_bib117","first-page":"1346","article-title":"Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS)","volume":"35","author":"Revicki","year":"2008","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.crohns.2009.11.005_bib118","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2790","article-title":"Physical function, disease activity, and health-related quality-of-life outcomes after 3years of adalimumab treatment in patients with ankylosing spondylitis","volume":"11","author":"van der Heijde","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.crohns.2009.11.005_bib119","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/00063030-200721020-00007","article-title":"Adalimumab: in Crohn\u2019s disease","volume":"21","author":"Plosker","year":"2007","journal-title":"BioDrugs"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994609001378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994609001378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/4\/3\/257\/1026981\/4-3-257.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:00:34Z","timestamp":1739458834000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2009.11.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1873994609001378"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2009.11.005","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}